Merck Proquad MMR/V Combo Vaccine Clears FDA With Approval For Second Round MMR Vaccination
This article was originally published in The Pink Sheet Daily
The measles, mumps, rubella and varicella vaccine will be priced at $120.25 for an individual single-dose vial.
You may also be interested in...
FDA has extended its review of Merck's measles, mumps, rubella and varicella vaccine ProQuad by three months until Sept. 30
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.
A Phase III trial will compare 40 mg/day glatiramer to the 20 mg/day approved dose.